A RANDOMIZED COMPARATIVE TRIAL OF SEQUENTIAL VERSUS ALTERNATING CYCLOPHOSPHAMIDE, DOXORUBICIN, AND CISPLATIN AND MITOMYCIN, LOMUSTINE, AND METHOTREXATE IN METASTATIC NON-SMALL-CELL LUNG-CANCER

被引：18

作者：

EAGAN, RT

FRYTAK, S

RICHARDSON, RL

CREAGAN, ET

THERNEAU, TM

COLES, DT

JETT, JR

机构：

来源：

关键词：

D O I：

10.1200/JCO.1988.6.1.5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：5 / 8

页数：4

共 13 条

[1] EAGAN RT, 1979, CANCER, V44, P1125, DOI 10.1002/1097-0142(197909)44:3<1125::AID-CNCR2820440348>3.0.CO
[2] 2-4
[3] PHASE-II STUDY OF THE 3-DRUG COMBINATION OF MITOMYCIN-C, CCNU, AND METHOTREXATE (MCM) IN ADVANCED NON-SMALL CELL LUNG-CANCER
EAGAN, RT
FRYTAK, S
RICHARDSON, RL
CREAGAN, ET
NICHOLS, WC
[J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1986, 9 (01): : 67 - 70
[4] EAGAN RT, 1977, CANCER TREAT REP, V61, P1339
[5] EVANS W K, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P169
[6] EVANS WK, 1981, CANCER TREAT REP, V65, P947
[7] GEHAN EA, 1965, BIOMETRIKA, V52, P203, DOI 10.1093/biomet/52.1-2.203
[8] GOLDIE JH, 1982, CANCER TREAT REP, V66, P439
[9] NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS
KAPLAN, EL
MEIER, P
[J]. JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) : 457 - 481
[10] KNOST JA, 1981, CANCER TREAT REP, V65, P974